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Tissue distribution of adenosine receptor mRNAs in the rat
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1 A degree of ambiguity and uncertainty exists concerning the distribution of mRNAs encoding the
four cloned adenosine receptors. In order to consolidate and extend current understanding in this area,
the expression of the adenosine receptors has been examined in the rat by use of in situ hybridisation and
the reverse transcription-polymerase chain reaction (RT-PCR).
2 In accordance with earlier studies, in situ hybridisation revealed that the adenosine A1 receptor was
widely expressed in the brain, whereas A2A receptor mRNA was restricted to the striatum, nucleus
accumbens and olfactory tubercle. In addition, A1 receptor mRNA was detected in large striatal
cholinergic interneurones, 26% of these neurones were also found to express the A2A receptor gene.
Central levels of mRNAs encoding adenosine A2B and A3 receptors were, however, below the detection
limits of in situ hybridisation.
3 The more sensitive technique of RT-PCR was then employed to investigate the distribution of
adenosine receptor mRNAs in the central nervous system (CNS) and a wide range of peripheral tissues.
As a result, many novel sites of adenosine receptor gene expression were identified. Al receptor
expression has now been found in the heart, aorta, liver, kidney, eye and bladder. These observations are
largely consistent with previous functional data. A2A receptor mRNA was detected in all brain regions
tested, demonstrating that expression of this receptor is not restricted to the basal ganglia. In the
periphery A2A receptor mRNA was also found to be more widely distributed than generally recognised.
The ubiquitous distribution of the A2B receptor is shown for the first time, A2B mRNA was detected at
various levels in all rat tissues studied. Expression of the gene encoding the adenosine A3 receptor was
also found to be widespread in the rat, message detected throughout the CNS and in many peripheral
tissues. This pattern of expression is similar to that observed in man and sheep, which had previously
been perceived to possess distinct patterns of A3 receptor gene expression in comparison to the rat.
4 In summary, this work has comprehensively studied the expression of all the cloned adenosine
receptors in the rat, and in so doing, resolves some of the uncertainty over where these receptors might
act to control physiological processes mediated by adenosine.
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Introduction
Currently four different adenosine receptors are recognised,
designated Al, A2A, A2B and A3. This classification is based on
both their protein sequences and affinity for a variety of li-
gands (Fredholm et al., 1994). These receptors play an integral
role in modulating the metabolic activity and function ofmany
tissue and cell types. Despite the pivotal role that adenosine
receptors play in a wide range of cellular functions, the ana-
tomical distribution of the cloned receptors' expression re-
mains poorly defined.
Adenosine Al receptor distribution is perhaps the most
extensively characterised. In the CNS, the presence of Al re-
ceptor protein has been demonstrated by ligand binding
(Alexander & Reddington, 1989; Weber et al., 1990) and im-
munohistochemistry (Rivkees et al., 1995), while the mRNA
has been detected by in situ hybridisation (Reppert et al.,
1991). However, less is known of the distribution of the other
receptors.
In the rat, A2A receptors are believed to be concentrated in
the striatum, nucleus accumbens, olfactory tubercle and lateral
segment of the globus pallidus (Jarvis & Williams, 1989; Par-
kinson & Fredholm, 1990). In the striatum, the A2A receptor is
thought to be exclusively expressed in the GABAergic stria-
topallidal neurones (Schiffman et al., 1991), although there is
now evidence of a functionally active receptor in striatal cho-
linergic neurones (Kurokawa et al., 1994). It has become ap-
Author for correspondence.
parent that the A2A receptor may also be present in other brain
areas including the hippocampus (Sebastiao & Ribeiro, 1992),
the nucleus tractus solitarius (Barraco et al., 1991) and the
cerebral cortex (Kirk & Richardson, 1995). It would therefore
appear as though the adenosine A2A receptor may be more
widely expressed in the CNS than was originally thought.
Northern blot analysis of rat tissue mRNA demonstrated
the greatest expression of the A2B receptor in caecum, large
intestine, and urinary bladder, with lesser amounts in brain,
spinal cord and lung (Stehle et al., 1992). Central expression
was investigated in the same study by in situ hybridisation;
however, a strong signal was only detected in the hypophyseal
pars tuberalis. Yet the ability of the A2B receptor to stimulate
adenylyl cyclase in brain slices has led to the suggestion that
the A2B receptor is in fact present throughout the brain (Daly
et al., 1983).
The distribution of the A3 receptor in the three species from
which it has been cloned would appear to vary. In the rat, A3
receptor mRNA was only detected in the testis (Meyerhof et
al., 1991; Zhou et al., 1992) by in situ hybridisation, although
by reverse transcription-polymerase chain reaction (RT-PCR),
A3 expression was also found in the heart, the lung and a
limited number of areas in the CNS (Zhou et al., 1992). In
contrast, significant expression of the human and sheep A3
receptor mRNAs have been observed in many peripheral tis-
sues, with lower levels in the central nervous system and testis
(Linden et al., 1993; Salvatore et al., 1993). It is therefore
generally accepted that this receptor shows a species-specific
tissue distribution (Linden et al., 1993).
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Current data on the distribution of the adenosine receptors
can therefore be seen to be both incomplete and confused. In
order to consolidate this situation and extend current under-
standing of the distribution of these important receptors,
adenosine receptor gene expression has been examined in the
rat by in situ hybridisation and the more sensitive technique of
RT-PCR, thereby identifying tissues and cells in which these
important receptors may be functionally active.
Methods
Collection of tissues
Male and female Sprague-Dawley rats (8-12 weeks) (Tucks,
Rayleigh, Essex), maintained in a 12 h light-dark cycle with
free access to laboratory rodent chow were killed by cervical
dislocation. Tissue was rapidly dissected out, snap frozen in
isopentane cooled by solid CO2 and stored at - 70'C for
subsequent sectioning and total RNA extraction.
In situ hybridisation
Cryostat sections (10 Mm) were thaw-mounted onto poly-L-
lysine-coated slides, fixed in phosphate buffered 4% para-
formaldehyde and stored in 95% ethanol at 40C. The basic
method used for in situ hybridisation has been described pre-
viously (Sirinathsinghji & Dunnett, 1993). Briefly, sense and
antisense oligodeoxyribonucleotide probes complementary to
the rat adenosine receptors were synthesised on a Biosearch
8700 DNA synthesiser and purified on 8% polyacrylamide/8 M
urea preparative sequencing gels. The sequence of the antisense
probes (Table 1) were unique to the individual rat adenosine
receptors. Probes were labelled with a-[35S]-dATP
(> 1000 Ci mmol 1, Amersham International plc, Amersham,
Bucks.) by terminal deoxynucleotidyl transferase (Pharmacia,
Milton Keynes, Bucks.) at 320C for 1 h. The labelled probe
was applied to sections in hybridisation buffer containing
4 x standard sodium citrate (SSC), 50% deionised formamide.
The slides were incubated overnight at 42°C before being
washed in 1 x SSC containing 0.1% sodium thiosulphate for
1 h at 55°C and dehydrated through alcohol. Slides were ex-
posed to X-ray film (Hyperfilm-,Bmax, Amersham) for 7 days,
dipped in Ilford K5 emulsion (Amersham), and stored desic-
cated at 4°C for 2 weeks. After development, sections were
stained with haematoxylin and eosin and mounted with a
coverslip.
Northern blots
Total RNA was isolated from tissue samples by acid guani-
dinium thiocyanate-phenol-chloroform extraction (Chirgwin
et al., 1979). Poly(A+) RNA was selected by oligo(dT) cellu-
lose chromatography, denatured in glyoxal, and separated by
electrophoresis on a 1.2% formaldehyde agarose gel prior to
transfer onto Hybond N membrane (Amersham). RNA was
fixed to the membrane by u.v. irradiation and molecular mass
markers were made visible by ethidium bromide staining. The
antisense probes used for in situ hybridisation were 3'-end la-
belled with [32P]-dATP (6000 Ci mmol'; NEN) and terminal
deoxynucleotidyl transferase (Pharmacia). After pre-
hybridisation at 42°C for 4 h, the blots were hybridised over-
night at 42°C with the 32P-labelled probe in hybridisation
buffer under conditions similar to those described for in situ
hybridisation, except that dextran sulphate was omitted from
the hybridisation buffer. After washing in 1 x SSC/0.1% so-
dium dodecyl sulphate at room temperature for 30 min and
then at 55°C for 30 min, the blot was wrapped in Saran wrap
and exposed to Kodak XAR X-ray film at - 70°C in X-ray
cassettes containing intensifying screens.
Reverse transcription PCR (RT-PCR)
PCR primers were synthesised from the adenosine receptor
cDNA sequences (Table 1). Total RNA (10 Mg) was reverse
transcribed in the presence of an anchored oligo dT-primer
T17(A,G,C), by use of M-MLV reverse transcriptase (Gibco
BRL, Paisley, Renfrewshire) to manufacturer's recommenda-
tions. Single stranded cDNA products were denatured and
subjected to PCR amplification (30 cycles). Each PCR cycle
consisted of denaturing at 94°C for 45 s, annealing at 64°C for
45 s, and extension at 72°C for 60 s. The reaction mixture
contained; 0.5 mM dNTPs, 1.2 u AmpliTaq DNA polymerase
(Applied Biosystems, Warrington, Cheshire), 0.5 u Perfect
match (Stratagene, Cambridge, Cambs.), 1 x PCR buffer
(3.5 mM Mg2+, pH 8.8). Amplification of fl-actin and sucrase-
isomaltase mRNA served as controls. The PCR products were
separated on 2.5% agarose gels. To aid comparison of the
distribution of the receptor mRNAs, all RT-PCR reactions
were performed on the same RNA preparation.
Table 1 Adenosine receptor-specific antisense probes, PCR primers and PCR product sizes
Accession Probe/
Receptor number Primer Nucleotides Sequence
Product Restriction
size Digest
Al M64299 Probe
Forward
Reverse
A2A L08102 Probe
Forward
1050-1006
630-649
836-818
632-588
407-423
5'-GGC GAT CTT CAG CTC CTT CCC GTA
GTA CTT CTG GGG GTC ACC GGA-3'
5' CTC CAT TCT GGC TCT GCT CG 3'
5'ACA CTG CCG TTG GCT CTC C 3'
5'-CGC CAT CCG AAT TCC ACT CCG GTA
CAA TGG CTT GGT GAC AGG TGT-3'
5' CCA TGC TGG GCT GGA ACA 3'
Reverse 556-536 5'GAA GGG GCA GTA ACA CGA ACG 3'
207 HaelII 101, 37, 69
150 HaeIII 87, 63
A2B M91466 Probe
Forward
Reverse
A3 M94152 Probe
Forward
619-575
139-156
298-281
366-321
238-256
5'-CAC TTC ACA GGG CAG CAG CTC TTA
TTC GTG ATG CCA TCC CCA GGT-3'
5'TGG CGC TGG AGC TGG TTA 3'
5'GCA AAG GGG ATG GCG AAG 3'
5'-GTA GGT GAT TTG CAA CCA CAA GGC
ACT CGT CGT GGT ATT GTT GGC-3'
5' AGA AGC TAG GTC CAC TGG C 3'
Reverse 902-880 5'GCA CAT GAC AAC CAG GGG GAT GA 3'
160 XhoI 71, 89
665 AluI 52, 6, 135,
222, 132, 14,
100
The fragment sizes given are those predicted from the receptor sequence upon complete digestion with the indicated restriction enzyme.
Fragment
sizes
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Restriction digest
Following RT-PCR, 15 pg of amplified adenosine receptor
cDNA was digested to completion at 370C for 1 h with the
specific endonucleases shown in Table 1 (Biolabs, New Eng-
land, U.S.A.). The digestion products were then separated on
2.5% agarose gels, and the fragment sizes predicted from the
receptor sequences are shown in Table 1.
A1 A2A A2BKb A3
9.5
4.4
2.4
1.4
Figure 1 Autoradiograph of Northern blots by use of adenosine
receptor specific anti-sense probes. Each 32P-labelled probe was
hybridised to 10,pg of poly(A+) RNA extracted from whole rat
brain. An RNA ladder was used to assess the sizes of mRNAs species
detected.
Results
In situ hybridisation histochemistry was used initially to in-
vestigate the expression of adenosine receptor mRNAs in rat
tissues. The specificity of the antisense probes was checked by
Northern blot analysis. Each antisense probe recognised RNA
transcripts of the appropriate size: 3.5 kb and 5.5 kb for the Al
receptor (Reppert et al., 1991), 2.6 kb for the A2A receptor
(Fink et al., 1992), 2.2 kb for the A2B receptor (Stehle et al.,
1992) and 1.8 kb for the A3 receptor (Meyerhof et al., 1991;
Figure 1). In addition, when complementary sense probes were
used under identical conditions to those used for antisense
probes no specific hybridisation was observed (Figure 2).
In situ hybridisation with the A1 receptor probe revealed a
similar distribution pattern to that previously observed (Ma-
han et al., 1991; Reppert et al., 1991), with the highest level of
Al mRNA detected in the cortex, hippocampus and cerebellum
(Figure 2). Examination of emulsion dipped slides revealed
that, with the exception of the caudate putamen, the cellular
localisation of Al receptor mRNA was also in accordance with
previous findings (Reppert et al., 1991). In the caudate puta-
men the Al receptor gene was found to be expressed exclusively
in the large neurones (approximately 30 pm in diameter)
(Figure 3). In situ hybridisation of the A2A receptor probe
confirmed the strong expression of the A2A receptor gene in the
striatum, olfactory tubercle and nucleus accumbens (Jarvis &
Williams, 1989; Parkinson & Fredholm, 1990), with apparently
no expression in other areas of the brain (Figure 2). Emulsion
dipped slides showed that the mRNA was concentrated in the
medium sized neurones (approximately 10 pm in diameter) of
the caudate putamen (Figure 3). Examination of the large
striatal neurones revealed specific hybridisation in 13/50 neu-
rones examined. The concentration of silver grains over these
cells appeared less than that over the medium sized cells, but
considerably greater than background (Figure 3). The A2B
receptor probe revealed no specific hybridisation pattern in the
rat brain, but there did appear to be weak uniform binding of
probe at levels slightly above background (Figure 2). By use of
in situ hybridisation, significant expression of the A3 receptor
mRNA was only detected in the testis, where the probe hy-
bridised specifically to the spermatocytes and the spermatids
(data not shown). No specific hybridisation was detectable in
the CNS (Figure 2), or any other peripheral tissues (data not
shown).
The PCR primers used are listed in Table 1. The specificity
of each PCR amplification was confirmed by restriction digest
(Figure 4). When assessing the presence or absence of receptor
mRNA transcripts in tissue samples the amplification of,B-
Figure 2 In situ hybridisation of adenosine receptor specific oligonucleotide probes. X-ray autoradiographs of horizontal (top) and
vertical (bottom) sections of rat brain after hybridisation of 35S-labelled adenosine receptor anti-sense probes and a representative
sense probe. Brain areas showing specific hybridisation are labelled: CT, cortex; Hip, hippocampus; CB, cerebellum; CP, caudate
putamen; TT, taenia tecta; PO, primary olfactory cortex; NA, nucleus accumbens; OT, olfactory tubercle. Scale bar= 0.5 cm.
1463
A.K. Dixon et a! Adenosine receptor gene expression
actin and sucrase-isomaltase mRNAs were used as controls
(Dixon et al., 1995); f-actin cDNA was used to confirm the
integrity of RNA preparations, thus guarding against false
negatives; amplification of the intestine-specific enzyme su-
crase-isomaltase (Chandrasena et al., 1992) was used in order
to control for false positives due to over sensitive PCR con-
ditions, or amplification of genomic DNA contamination.
RT-PCR revealed expression of the adenosine Al receptor
gene in all the brain areas tested (Figure 5). In the periphery
the Al receptor transcript was also observed in the heart, aorta,
spleen, kidney, liver, testis, eye and bladder. In each case the
amount of amplified product was lower than that observed in
the CNS. Very low levels of amplification product were de-
tected in samples from the lung, uterus and stomach, while
none were observed in samples derived from the skin, skeletal
muscle, jejunum and proximal colon.
RT-PCR revealed a much wider distribution of the adeno-
sine A2A receptor transcript than previously described, with an
amplification product being observed in all areas of the CNS
(Figure 5). High levels of amplification product were observed
in the striatum, nucleus accumbens, and thalamus with lower
levels in every other brain region tested. In the periphery A2A
receptor mRNA transcript was also detected in RNA samples
derived from many different tissues. The highest degree of
amplification product was seen in the eye and skeletal muscle,
with lower amplification in the heart, lung, bladder, and
uterus. Even lower levels were detected in the aorta, spleen,
stomach, testis, skin, kidney and liver. No amplification pro-
duct was observed in samples from the jejunum and proximal
colon.
RT-PCR revealed the adenosine A2B receptor gene to be
uniformly expressed throughout the CNS. In the periphery the
highest amount of amplification product was seen in samples
from the proximal colon followed by the eye, lung, uterus and
bladder, lower levels in the aorta, stomach, testis, and skeletal
muscle. Lowest levels of product were detected in the jejunum,
kidney, heart and skin with trace levels detectable in the spleen
and liver (Figure 5).
RT-PCR revealed the presence of A3 receptor mRNA in all
regions of the brain studied. The specific amplification product
was detected in samples from the striatum, olfactory bulb,
nucleus accumbens, hippocampus, hypothalamus, thalamus,
and cerebellum, with slightly lower levels in the cortex and
amygdala (Figure 5). In peripheral tissues the strongest signal
was observed in samples from spleen, lung, uterus and testis;
with moderate levels of the amplification product from the
liver and bladder, and very low levels in the heart, aorta, sto-
mach, jejunum, proximal colon, kidney and eye; while no de-
tectable PCR product was observed with skin and skeletal
muscle RNA.
Discussion
This paper describes the tissue distribution of mRNAs en-
coding the 4 cloned adenosine receptors in the rat. In situ hy-
bridisation was used initially to define the tissue and cellular
localisation of adenosine receptor gene expression, but failed
to detect mRNA in some locations thought to possess the
functional protein. We therefore employed the more sensitive
Figure 3 Bright-field emulsion autoradiographs illustrating adenosine A1 and A2A receptor gene expression in the rat striatum. (a)
Silver grains demonstrate A1 receptor mRNA associated with large sized (indicated by arrow), but not medium sized cells of the
striatum; (b) A2A receptor probe hybridisation to both large sized and medium sized cells of the striatum; (c) A2A receptor probe
hybridisation to medium sized, but not large cells of the striatum. Scale bar= 50,um.
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technique of RT-PCR to investigate the expression of this
important family of receptors.
The distribution of the Al receptor has been examined
previously by in situ hybridisation (Reppert et al., 1991), re-
ceptor autoradiography (Goodman & Snyder, 1982; Alexander
& Reddington, 1989; Weber et al., 1990) and, more recently, by
immunohistochemistry (Rivkees et al., 1995). Results of the
current in situ hybridisation study were very similar to those
previously obtained, confirming the accepted central pattern of
expression for the adenosine Al receptor gene. In the caudate
putamen previous in situ hybridisation studies failed to detect
Al receptor mRNA (Reppert et al., 1991), although the Al
receptor protein has been detected by immunohistochemistry
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Figure 4 Restriction endonuclease digest of adenosine receptor RT-
PCR products. Adenosine receptor specific RT-PCR was performed
on rat whole brain total RNA as described in the Methods section.
cDNA products (1I5 g) were digested with the restriction enzyme
indicated, separated on 2.5% agarose gels and stained with ethidium
bromide. Sizes of PCR and digest products are given in base pairs.
(a) Al receptor product digested with Hae III; (b) A2A receptor
product digested with Hae III; (c) A2B receptor product digested with
Xho I; (d) A3 receptor product digested with Alu I. Expected sizes of
digest fragments are indicated below in schematic diagrams and
Table 1. v Represents a restriction site on the amplified sequence.
in 38% of neurones in this brain region (Rivkees et al., 1995).
Interestingly, we detected specific labelling to the large (30-
50 pm) neurones in the caudate putamen (Figure 3), and since
these large neurones correspond to the cholinergic inter-
neurones (Bolam et al., 1984), this is consistent with the ability
of the Al receptor to inhibit striatal acetylcholine release (Ri-
chardson et al., 1987).
The results of the RT-PCR presented here show Al receptor
gene expression throughout the CNS and also in a wide variety
of peripheral tissues. In addition to those tissues found to ex-
press the Al receptor gene by Northern blot analysis (brain,
spinal cord, epididymis plus vas deferens, testis white adipose
tissue, stomach, spleen, pituitary and adrenal, Reppert et al.,
1991), we detected Al receptor mRNA in the heart, aorta,
kidney, liver, eye and bladder. Functional effects of the Al
receptor in the periphery have been observed in the heart
(Mullane & Williams, 1990), the spleen (Fozard & Milavec-
Krizman, 1993), the liver (Ohigashi et al., 1993), the eye
(Blazynski, 1990), the aorta (Conti et al., 1993), the stomach
(Christofi et al., 1992), the colon (Jarvis et al., 1994) and the
bladder (Foster & Ferguson, personal communication). Al
receptor mRNA has also been previously found in the testis
(Rivkees, 1994), spleen and liver (Stehle et al., 1992). Very low
levels of A1 receptor amplification were also observed in the
lung which is consistent with the low functional activity of this
receptor in the non-allergic lung (Ali et al., 1994). The RT-
PCR also suggested the presence of low levels of this receptor
transcript in the kidney, where the Al receptor controls blood
flow and renin secretion (Churchill & Bidani, 1990). A similar
low level (or absence) of Al receptor mRNA in the kidney and
small intestine was shown by Reppert et al., (1991) and Stehle
et al. (1992). It is interesting that we failed to detect Al receptor
mRNA in the jejunum even though an Al-like receptor has
been shown to be active in this tissue (Hancock & Coupar,
1995). Thus, the tissue distribution of the Al mRNA transcript
has been extended by RT-PCR primarily to those tissues in
which a functional Al receptor has been reported.
Previous in situ hybridisation studies have demonstrated
that the A2A receptor mRNA is concentrated in the striato-
pallidal GABAergic projection neurones of the striatum
(Schiffman et al., 1991; Fink et al., 1992), consistent with the
overall pattern of hybridisation observed in this study (Figure
3b,c). However, the earlier studies failed to detect A2A ex-
pression in the large striatal cholinergic interneurones and
therefore it is of particular interest that 13 out of 50 of these
cells examined here, contained A2A mRNA (Figure 3b). This is
concordant with the control of striatal acetylcholine release by
the A2A receptor (Brown et al., 1990; Kirk & Richardson, 1993;
1994; Jin et al., 1993; Kurokawa et al., 1994). Our in situ hy-
bridisation studies failed to detect A2A receptor mRNA in any
brain areas other than the striatum, nucleus accumbens and
olfactory tubercle (Figure 2) despite functional evidence for the
presence of this receptor in the hippocampus (Cunha et al.,
1994a,b), the cortex (O'Regan et al., 1992; Simpson et al.,
1992; Kirk & Richardson, 1995) and the nucleus tractus soli-
tarius (Barraco et al., 1991). Therefore, the much more sensi-
tive technique of RT-PCR was employed to investigate the
distribution ofA2A receptor gene expression in the rat CNS. As
expected the highest levels of amplification product were ob-
served in samples from the striatum and nucleus accumbens
but in addition lower levels of amplification product were
observed in all other brain regions examined (Figure 5). The
low levels of amplification product detected in samples from
the cortex are consistent with previous ligand binding results
which suggested that the abundance of this receptor in the
cortex was less than 20% of that in the striatum (Kirk & Ri-
chardson, 1995). The widespread expression of the A2A re-
ceptor transcript is similar to that seen in the developing rat
brain (Weaver, 1993). These data suggest that this receptor
should no longer be viewed as having a restricted distribution
in the CNS and that the observed extra-striatal effects of A2A
receptor ligands could be due to their action on the cloned
receptor.
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Figure 5 Tissue distribution of adenosine receptor mRNA expression as examined by RT-PCR. RT-PCR was performed using l0,ug of total
RNA extracted from a wide range of rat tissues as described using the 5' and 3' primers shown in Table 1. RT-PCR of fJ-actin and sucrase-
isomaltase mRNAs serve as controls. PCR products were separated on a 2.5% agarose gel and visualised with ethidium bromide. Sizes of PCR
products are given in base pairs.
In the periphery, A2A receptor function has been detected in
the heart (Martin et al., 1993), retina (McIntosh & Blazynski,
1994), aorta (Conti et al., 1993), and a variety of blood cells
(Cronstein & Hirschhorn, 1990). The data presented here ex-
tend the distribution of this receptor to include the testis,
where previous in situ hybridisation studies had failed to detect
this transcript (Rivkees, 1994), spleen, lung, uterus, skin,
bladder and skeletal muscle. This is in addition to the thymus,
vas deferens, epididymal fat pad, oesophagus and liver (Stehle
et al., 1992) and supports the presence of the A2A receptor in
many peripheral tissues.
The A2B receptor cloned by Stehle et al. (1992) has not been
as well studied as the other adenosine receptors, although it
has been shown (by Northern blot analysis) to be present in the
caecum, large intestine and bladder; with lower levels in the
brain, spinal cord, lung, vas deferens and pituitary (Stehle et
al., 1992). In situ hybridisation studies failed to detect a specific
pattern of A2B receptor mRNA distribution in the brain;
however, hybridisation levels did appear to be slightly above
background (Figure 2). RT-PCR studies suggest a more
widespread distribution of the A2B receptor gene expression
than found previously, some degree of amplification being
observed in every tissue studied, highest in the proximal colon
and lowest in the liver (Figure 5). The transcript was also de-
tected in every brain area examined, supporting the suggestion
that this receptor is present throughout the brain (Daly et al.,
1983). Such a ubiquitous yet low level of expression through-
out the CNS would explain our inability, and that of Stehle et
al. (1992), to detect a pattern of expression by in situ hy-
bridisation in the CNS. It is possible that adenosine A2A and
A2B receptor expression in vascular endothelial and smooth
muscle cells may have contributed to the expression pattern of
these genes. However, it is evident from the variable amount of
amplification product from each tissue sample, negative and
trace through to strongly positive, that the contribution of
signal obtained from these sources to the overall pattern of
expression is relatively small in comparison to amplification of
A2 mRNAs from other cell types in those tissues.
The rat A3 receptor was originally detected in the testis with
low levels in the brain (Zhou et al., 1992). Some recent func-
tional studies have suggested that the A3 receptor may also be
involved in the regulation of cerebral blood flow (von Lubitz et
al., 1994), the induction of hypotension (Fozard & Carruthers,
1993), mast cell activation (Ramkumar et al., 1993), contrac-
tion of the spleen (Linden, 1994) and behavioural depression in
mice (Jacobson et al., 1993). However, in our initial studies we
were only able to detect A3 receptor mRNA by in situ hy-
bridisation in the testis (data not shown), perhaps because it is
concentrated in a small subset of cells (i.e. the spermatocytes
and spermatids) in this tissue. In contrast, RT-PCR revealed
the expression of the A3 receptor gene in every brain region
studied (Figure 5). In the periphery, moderate amounts of
amplification product were observed from the spleen, liver,
lung, uterus, testis, bladder, with lower levels from the heart,
jejunum, proximal colon, kidney and eye. A3 receptor mRNA
was not detected in skin or skeletal muscle. This extends
considerably the distribution found by Zhou et al. (1992). The
strong expression in the spleen is consistent with the suggestion
that A3 receptors may be involved in contraction in this tissue
(Linden, 1994), while that in the lung is of interest since the A3
receptor may be involved in mast cell activation (Ramkumar et
al., 1993) and may be a suitable target for anti-asthmatic drugs
(Linden, 1994). The widespread expression of the adenosine A3
receptor in rat tissues, is similar to that observed for this re-
ceptor in human and sheep tissues (Linden, 1994). This sug-
gests that the previously observed species-specific pattern ofA3
receptor gene expression may be due to quantitative differences
in the abundance of this transcript between species and tissues,
rather than the perceived qualitative variation.
The results presented herein consolidate and expand the
current understanding of adenosine receptor distribution in the
rat. Al receptor gene expression was observed, in addition to
previously identified tissues, in the heart, aorta, liver, eye and
bladder. A2A receptor mRNA was detected in all brain regions
tested, demonstrating that expression of this receptor is not
restricted to the basal ganglia. In the periphery, A2A receptor
1466
A.K. Dixon et al Adenosine receptor gene expression 1467
mRNA was also found to be more widely distributed than
previously recognised. The ubiquitous expression of the A2B
receptor was shown for the first time, with A2B receptor
mRNA detected in all rat tissues studied. A3 receptor mRNA
was detected throughout the CNS and in many peripheral
tissues. This pattern of expression is similar to that observed in
the human and sheep, suggesting that the adenosine A3 re-
ceptor ought no longer to be considered to have a species-
specific distribution. These observations should be taken into
consideration in future studies into the pharmacology and
physiology of this important family of receptors.
T.C.F. is funded by the Wellcome Trust and A.K.D. is a BBRC
funded research student.
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